Study Evaluating 5 Doses of RPL554 and Placebo in COPD Patients Via a Dry Powder Inhaler

Clinical trial NCT04027439 · COMPLETED

Trial details

NCT number

NCT04027439

Sponsor

Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2018-12-10

Primary completion

2019-05-23

Enrollment

37

View on ClinicalTrials.gov